AUS
NZ
UK
CA
USA
IND
Health
Mersana Therapeutics (NASDAQ: MRSN) Announces Positive Initial Clinical Data for Emi-Le in Cancer Treatment
January 10, 2025 04:59 AM PST| By Team Kalkine MediaHighlights,Emi-Le demonstrated a 23% objective response rate in B7-H4 high tumors at intermediate doses.,No Grade 4 or 5 treatment-related adverse events were observed during the Phase 1 trial.,Mersana's differentiated safety profile with limited sev...
Pediatrix Medical Group (MD) Shows Strong Performance, Analysts React Positively
January 09, 2025 08:57 PM PST| By Team Kalkine MediaHeadlines,Analysts Raise Outlook on Pediatrix Medical Group,Positive Trends Seen in Recent Earnings,Strong Stock Movement and Financial Metrics,Pediatrix Medical Group,,(NYSE:MD),has caught the attention of analysts following recent evaluations. Seve...
Johnson & Johnson Faces Market Movement Amid Analyst Perspectives
January 09, 2025 10:25 AM PST| By Team Kalkine MediaHeadlines,Johnson & Johnson has recently experienced notable stock price movements amidst increased trading volumes.,Analysts have provided a range of perspectives, reflecting mixed sentiment on the company’s future outlook.,The company’s strategic i...
AptarGroup (NYSE:ATR) Shows Resilience with Strong Institutional Backing
January 09, 2025 08:00 AM PST| By Team Kalkine MediaHighlights,AptarGroup has initiated a $500 million program to enhance its capital structure.,Institutional investors control 88.52% of AptarGroup’s shares, reflecting high confidence.,The stock has recently traded between a 52-week low of $122.97 and...
Stryker (NYSE:SYK) Exceeds Earnings Expectations with Strong Quarterly Results
January 09, 2025 08:00 AM PST| By Team Kalkine MediaHighlights,Stryker beats earnings expectations with strong quarterly results.,Institutional investors show growing confidence by increasing their stakes.,Stryker continues to lead in orthopaedics and neurotechnology sectors.,Stryker Corporation has d...
Navigating Debt and Operational Challenges at Elanco Animal Health (NYSE:ELAN)
January 08, 2025 10:51 AM PST| By Team Kalkine MediaHighlights,Elanco Animal Health carries a significant debt load relative to its market value.,The company's low interest coverage ratio raises concerns about its financial flexibility.,Strong free cash flow helps mitigate some of the risks posed by i...
STERIS Gains Institutional Confidence with Strategic Stake Adjustments
January 08, 2025 09:58 AM PST| By Team Kalkine MediaHeadlines,GAMMA Investing LLC adjusts its holdings in STERIS,Institutional investors show increased interest in STERIS,Strong institutional backing for STERIS as investors expand positions,GAMMA Investing LLC Adjusts Stake in STERIS,GAMMA Investing L...
Bristol-Myers Squibb (NYSE:BMY) Reports Robust Quarterly Earnings
January 08, 2025 09:39 AM PST| By Team Kalkine MediaHighlights,Bristol-Myers Squibb beats quarterly earnings estimates.,Dividend increased, maintaining strong returns.,Insider activity shows strategic share adjustments.,Bristol-Myers Squibb Company continues to make significant strides in the healthca...
Humana Inc. Delivers Strong Earnings, Boosts Market Confidence (NYSE:HUM)
January 08, 2025 08:15 AM PST| By Team Kalkine MediaHighlights,Humana Inc. sees strong analyst interest with positive recommendations.,Recent quarterly earnings surpassed estimates, showcasing financial strength.,Humana maintains consistent dividend payments, offering stability to shareholders.,Humana...
Why Is 111, Inc. Shifting Its ADS StrategyWhy Is 111, Inc. Shifting Its ADS Strategy??
January 08, 2025 02:40 AM PST| By Team Kalkine MediaHighlights,111, Inc. has announced a change to its ADS ratio.,The new ratio will shift from 1 ADS representing 2 Class A ordinary shares to 1 ADS representing 20 Class A ordinary shares.,Trading will continue under the Nasdaq ticker symbol 'YI' with...
What’s Behind the Recent Struggles of Apogee Therapeutics' Stock?
January 08, 2025 02:30 AM PST| By Team Kalkine MediaHighlights,Apogee Therapeutics operates within the biotechnology sector, focused on medical innovation.,Market capitalization of $2.23 billion with notable fluctuations in its stock price over the past year.,Beta coefficient of 2.26 reflects higher s...
Regent Peak Wealth Adjusts Stake in Johnson & Johnson
January 07, 2025 10:59 AM PST| By Team Kalkine MediaHeadlines,Regent Peak Wealth Advisors Adjusts Stake in Johnson & Johnson,Other Institutional Investors Make Strategic Adjustments to Holdings,Johnson & Johnson's Institutional Ownership Remains Strong,Johnson & Johnson (NYSE:JNJ) Ownership Adjustment...
Rising Stake in Mettler-Toledo International (NYSE:MTD) Amid Institutional Demand
January 07, 2025 09:10 AM PST| By Team Kalkine MediaHighlights,Pensionfund Sabic increases stake in Mettler-Toledo International by 53.3%.,JPMorgan Chase & Co. and other institutional investors make significant adjustments.,Mettler-Toledo's performance continues to gain investor confidence.,Mettler-To...
How Bristol-Myers Squibb Manages Debt with Strong Earnings (NYSE:BMY)
January 07, 2025 08:51 AM PST| By Team Kalkine MediaHighlights,Bristol-Myers Squibb manages its debt effectively with solid earnings.,A substantial cash reserve supports the company's debt obligations.,Debt-to-EBITDA ratio and strong interest coverage signal sound financial management.,Bristol-Myers S...
Select Medical Sees Positive Momentum in Latest Financial Results (NYSE:SEM)
January 07, 2025 08:45 AM PST| By Team Kalkine MediaHighlights,Select Medical posted a strong quarterly revenue increase.,The company's net margin stands at 3.97%, reflecting solid profitability.,Institutional investors significantly boosted their stakes in Select Medical.,Select Medical Holdings cont...
How Bristol-Myers Squibb Manages Debt with Strong Earnings (NYSE:BMY)
January 07, 2025 08:44 AM PST| By Team Kalkine MediaHighlights,Bristol-Myers Squibb manages its debt effectively with solid earnings.,A substantial cash reserve supports the company's debt obligations.,Debt-to-EBITDA ratio and strong interest coverage signal sound financial management.,Bristol-Myers S...
Cencora, Inc. (NYSE:COR) Shows Resilience with Dividend Increase
January 07, 2025 08:35 AM PST| By Team Kalkine MediaHighlights,Nordea Investment Management AB increases stake in Cencora, Inc. by 40.2%.,Cencora boosts dividend payout, signaling positive performance.,Institutional investors hold 97.52% of Cencora’s stock.,Nordea Investment Management AB has signific...
Is Verona Pharma's Debt Position Putting Its Growth at Risk?
January 07, 2025 03:14 AM PST| By Team Kalkine MediaHighlights:,Debt acts as a means for companies to access capital, but it introduces risks if not managed effectively.,Mismanagement of debt can lead to shareholder dilution and, in extreme cases, bankruptcy.,It is important to evaluate a company’s de...
Is Cortexyme's Recent Price Movement a Sign of a Bigger Shift in Market Sentiment?
January 07, 2025 02:41 AM PST| By Team Kalkine MediaHighlights:,Cortexyme's,(NASDAQ:CRTX),stock surpassed its two hundred day moving average.,The stock reached a high of $1.95 during trading.,A total of 118,865 shares were traded on the day.,Biotechnology is a dynamic sector focused on the development...
Stryker (NYSE: SYK) to Acquire Inari Medical (NASDAQ: NARI) for $4.9 Billion, Strengthening VTE Treatment Portfolio
January 06, 2025 10:33 PM PST| By Team Kalkine MediaHighlights,Stryker agrees to acquire Inari Medical for $80 per share, totaling $4.9 billion,Acquisition strengthens Stryker’s position in the venous thromboembolism (VTE) treatment market,Expected to close by the end of Q1 2025, pending regulatory ap...
